Table 1.
Non-Propensity Matched (n = 3227) |
Propensity Matched (n = 490) |
||||||
---|---|---|---|---|---|---|---|
CPR (n = 317) | No CPR (n = 2910) | p-value | CPR (n = 245) | No CPR (n = 245) | p-value | ||
Demographics | Demographics | ||||||
Age, mean ± SD, y* | 64.3 ± 14 | 71.0 ± 13 | < 0.0001 | *Age, mean ± SD, y* | 65.6 ± 13 | 65.9.0 ± 13 | 0.7657 |
Sex | *Sex | ||||||
Male | 206 (65.0%) | 1751 (61.2%) | 0.1915 | Male | 163 (66.5%) | 170 (69.4%) | 0.4980 |
Female | 111 (35.0%) | 1109 (38.8%) | Female | 82 (33.5%) | 75 (30.6%) | ||
Race | *Race | ||||||
Black | 125 (39.4%) | 711 (24.4%) | <0.0001 | Black | 84 (34.3%) | 89 (36.3%) | 0.6006 |
White | 157 (49.5%) | 1768 (60.8%) | White | 129 (52.7%) | 131 (53.5%) | ||
Other | 35 (11.0%) | 431 (14.8%) | Other | 32 (13.1%) | 25 (10.2%) | ||
Comorbidities | Comorbidities | ||||||
Hypertension | 222 (70.0%) | 1784 (61.3%) | 0.0024 | *Hypertension | 174 (71.0%) | 166 (67.8%) | 0.4329 |
Diabetes | 161 (50.8%) | 1158 (39.8%) | 0.0002 | *Diabetes | 124 (50.6%) | 115 (46.9%) | 0.4160 |
Chronic Pulmonary Disease | 53 (16.7%) | 605 (20.8%) | 0.0876 | *Chronic Pulmonary Disease | 33 (13.5%) | 33 (13.5%) | >0.9999 |
Congestive Heart Failure | 47 (14.8%) | 472 (16.2%) | 0.5213 | *Congestive Heart Failure | 29 (11.8%) | 20 (8.2%) | 0.1753 |
Chronic Kidney Disease | 67 (21.1%) | 640 (22.0%) | 0.7260 | *Chronic Kidney Disease | 40 (16.3%) | 31 (12.7 %) | 0.2481 |
Dialysis-Dependent Kidney Failure | 23 (7.3%) | 118 (4.1%) | 0.0081 | Dialysis-Dependent Kidney Failure | 14 (5.7%) | 12 (4.9%) | 0.6869 |
Stroke | 30 (9.5%) | 395 (13.6%) | 0.0399 | Stroke | 24 (9.8%) | 28 (11.4%) | 0.5574 |
Cancer | 22 (6.9%) | 337 (11.6%) | 0.0126 | *Cancer | 14 (5.7%) | 8 (3.3%) | 0.1906 |
Outcomes | Outcomes | ||||||
Palliative Care Consultation | 63 (19.9%) | 564 (19.4%) | 0.8334 | Palliative Care Consultation | 45 (18.4%) | 53 (21.6%) | 0.3663 |